Abrunhosa-Branquinho, André N <br/><br/>
Radiotherapy quality assurance for the RTOG 0834/EORTC 26053-22054/NCIC CTG CEC.1/CATNON intergroup trial "concurrent and adjuvant temozolomide chemotherapy in newly diagnosed non-1p/19q deleted anaplastic glioma": Individual case review analysis.  [electronic resource] 

 -  Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology  May 2018 
 - 292-298 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1879-0887 
<br/><br/><label>Standard No.: </label>10.1016/j.radonc.2018.03.013  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents, Alkylating--therapeutic use<br/>Brain Neoplasms--drug therapy<br/>Chemotherapy, Adjuvant<br/>Chromosome Deletion<br/>Chromosomes, Human, Pair 1<br/>Chromosomes, Human, Pair 19<br/>Dacarbazine--analogs & derivatives<br/>Glioma--drug therapy<br/>Humans<br/>Prospective Studies<br/>Quality Assurance, Health Care<br/>Radiotherapy Planning, Computer-Assisted--methods<br/>Retrospective Studies<br/>Temozolomide<br/>Tomography, X-Ray Computed--methods